UK Government invests £5m to develop ‘library’ of MRNA vaccines
CPI has received a £5 million investment to support the development of an mRNA ‘vaccine library’ as part of the Government’s vaccine support package announced in the Budget by the chancellor, Rishi Sunak.
The vaccine...
How a Novel Drug Discovery Technology Could Help in the Fight Against COVID-19
By Dr Asif Tulah, Alcyomics
Alcyomics has been adapting its service provision and assays to play their part in the race to find new treatments for COVID-19 (SARS-CoV-2) and to better understand how this virus works....
UK STRIDES INTO INTERNATIONAL ARENA OF VACCINE DEVELOPMENT
As Oxford University and Imperial College London move into poll position in the race to develop an anti-Covid vaccine, the UK’s first dedicated Vaccines Manufacturing Innovation Centre is preparing to turn their results into...
Over 1,000 genes linked to severe COVID-19
Researchers from the University of Sheffield and Stanford University in the US have discovered specific genetic signals in people who develop severe coronavirus infection.
Age, body mass index and pre-existing health problems are known to...
BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST-COVID-19
Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity
As the world prepares to enter the next phase of the COVID-19 pandemic with the potential...
Call to address lack of patient diversity in research
By Kate Shaw, CEO of Innovative Trials.
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the issue of patient diversity in...
Fishing for answers to the covid conundrum
The eyes of the scientific world have been on a Covid-stricken fishing vessel that seems to have provided the first real evidence outside of a lab that antibodies do indeed protect against reinfection. By...
The scientific, political and economic implications of COVID-19: an insider’s perspective
It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This...
The UK’s first dedicated Vaccines Manufacturing Innovation Centre
The world class centre that will give the UK sovereign resilience and a global platform in the fight against Covid and many other diseases besides.
The Vaccines Manufacturing and Innovation Centre, a not-for-profit organisation established...
Covid-19 transmission chains in the UK traced through time and space with remarkable accuracy...
A team of scientists, led by researchers from the Universities of Oxford and Edinburgh, has analysed the first wave of the Covid-19 outbreak in the UK and produced the most fine-scaled and comprehensive genomic...
COVID-19 deaths among elderly may be due to genetic limit on cell division
Your immune system’s ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease. These cloned immune cells...
BioScience Today Launches Digital Packages to Support Companies During the COVID-19 Pandemic
As the Bio-Life science industry continues to be impacted by the COVID-19 pandemic, it is has become even more vital for companies to sustain their presence during these challenging times.
Since the COVID-19 pandemic...
COVID-19 TESTING SECTOR DEMAND SET TO CONTINUE AMID VACCINE ROLLOUT
Amid the continued high demand for testing and staggered vaccine rollout, the diagnostics industry, which was valued in 2020 at $17.2bn-$19.8bn, is set to rise further in 2021
The diagnostics sector will continue to see...
Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools...
Alex Bone, Patent Attorney, Partner, AA Thornton
The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention...
Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery
University of Birmingham researchers are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs.
The encounter complex is formed...
Work begins on UK system for estimating COVID-19 cases from wastewater
Scientists will develop a standardised UK-wide system for detecting coronavirus in wastewater, in order to provide an early warning of future outbreaks and reduce reliance on costly testing of large populations.
The majority of people...